advertisement

Topcon

Cioffi GA 24

Showing records 1 to 24 | Display all abstracts from Cioffi GA

94341 Patient Concerns Regarding Suspended Ophthalmic Care Due to COVID-19
Dar S
Journal of Glaucoma 2021; 30: 750-757
95197 Manhattan Vision Screening and Follow-up Study in Vulnerable Populations (NYC-SIGHT): Design and Methodology
Hark LA; Kresch YS
Journal of Glaucoma 2021; 30: 388-394
94341 Patient Concerns Regarding Suspended Ophthalmic Care Due to COVID-19
De Moraes CG; Karani R
Journal of Glaucoma 2021; 30: 750-757
95197 Manhattan Vision Screening and Follow-up Study in Vulnerable Populations (NYC-SIGHT): Design and Methodology
De Moraes CG; Horowitz JD
Journal of Glaucoma 2021; 30: 388-394
94341 Patient Concerns Regarding Suspended Ophthalmic Care Due to COVID-19
Khan S
Journal of Glaucoma 2021; 30: 750-757
95197 Manhattan Vision Screening and Follow-up Study in Vulnerable Populations (NYC-SIGHT): Design and Methodology
Park L
Journal of Glaucoma 2021; 30: 388-394
94341 Patient Concerns Regarding Suspended Ophthalmic Care Due to COVID-19
Chen R; Blumberg D
Journal of Glaucoma 2021; 30: 750-757
95197 Manhattan Vision Screening and Follow-up Study in Vulnerable Populations (NYC-SIGHT): Design and Methodology
Auran JD
Journal of Glaucoma 2021; 30: 388-394
94341 Patient Concerns Regarding Suspended Ophthalmic Care Due to COVID-19
Harizman N
Journal of Glaucoma 2021; 30: 750-757
95197 Manhattan Vision Screening and Follow-up Study in Vulnerable Populations (NYC-SIGHT): Design and Methodology
Gorroochurn P; Stempel S
Journal of Glaucoma 2021; 30: 388-394
94341 Patient Concerns Regarding Suspended Ophthalmic Care Due to COVID-19
Krawitz B; Valenzuela IA
Journal of Glaucoma 2021; 30: 750-757
95197 Manhattan Vision Screening and Follow-up Study in Vulnerable Populations (NYC-SIGHT): Design and Methodology
Maruri SC
Journal of Glaucoma 2021; 30: 388-394
94341 Patient Concerns Regarding Suspended Ophthalmic Care Due to COVID-19
Aliancy J
Journal of Glaucoma 2021; 30: 750-757
95197 Manhattan Vision Screening and Follow-up Study in Vulnerable Populations (NYC-SIGHT): Design and Methodology
Stidham EM
Journal of Glaucoma 2021; 30: 388-394
94341 Patient Concerns Regarding Suspended Ophthalmic Care Due to COVID-19
Tezel T
Journal of Glaucoma 2021; 30: 750-757
95197 Manhattan Vision Screening and Follow-up Study in Vulnerable Populations (NYC-SIGHT): Design and Methodology
Banks AZ; Saaddine JB
Journal of Glaucoma 2021; 30: 388-394
94341 Patient Concerns Regarding Suspended Ophthalmic Care Due to COVID-19
Horowitz J; Bearelly S
Journal of Glaucoma 2021; 30: 750-757
95197 Manhattan Vision Screening and Follow-up Study in Vulnerable Populations (NYC-SIGHT): Design and Methodology
Lambert BC; Pizzi LT
Journal of Glaucoma 2021; 30: 388-394
94341 Patient Concerns Regarding Suspended Ophthalmic Care Due to COVID-19
Coleman DJ
Journal of Glaucoma 2021; 30: 750-757
95197 Manhattan Vision Screening and Follow-up Study in Vulnerable Populations (NYC-SIGHT): Design and Methodology
Sapru S
Journal of Glaucoma 2021; 30: 388-394
94341 Patient Concerns Regarding Suspended Ophthalmic Care Due to COVID-19
Chang S; Cioffi GA
Journal of Glaucoma 2021; 30: 750-757
95197 Manhattan Vision Screening and Follow-up Study in Vulnerable Populations (NYC-SIGHT): Design and Methodology
Price S; Williams OA
Journal of Glaucoma 2021; 30: 388-394
94341 Patient Concerns Regarding Suspended Ophthalmic Care Due to COVID-19
Liebmann JM
Journal of Glaucoma 2021; 30: 750-757
95197 Manhattan Vision Screening and Follow-up Study in Vulnerable Populations (NYC-SIGHT): Design and Methodology
Cioffi GA; Liebmann JM
Journal of Glaucoma 2021; 30: 388-394

Issue 22-2

Change Issue


advertisement

Nidek